Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with type 2 diabetes

被引:56
作者
Lv, Ke [1 ]
Guo, Yingjun [1 ]
Zhang, Yiliang [1 ]
Wang, Kaiyu [1 ]
Jia, Yin [1 ]
Sun, Shuhan [1 ]
机构
[1] Second Mil Med Univ, Dept Med Genet, Shanghai 200433, Peoples R China
关键词
microRNAs; 3 ' untranslated region; DNA sequence polymorphism; insulin-like growth factor 2 receptor; translational regulation; type; 2; diabetes;
D O I
10.1016/j.bbrc.2008.06.102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The biological mechanism of a recent discovered association of type 2 diabetes with the ACAA-insertion/deletion polymorphism at the 3'UTR of the IGF2R gene has remained unclear. A very recently emerging novel polymorphic control layer by microRNAs (miRNAs) makes it possible to elucidate this issue. In this Study, a prediction by web tools MicroInspector and miRanda demonstrated that DNA sequence polymorphism (DSPs) ACAA-insertion/deletion in IGF2R 3'UTR is located within the hsa-miR-657 and hsa-miR-453 binding sites. And luciferase reporter assay revealed that hsa-miR-657 acts directly at the 3'UTR of the IGF2R. Furthermore, ACAA-deletion exerted a further repression Compared with ACAA-insertion, indicating that hsa-miR-657 regulates IGF2R gene expression in a polymorphic Control manner. Importantly, we also demonstrated that hsa-miR-657 can translationally regulate the IGF2R expression levels in Hep G2 cells. Thus, our findings testify the possibility that the ACAA-insertion/deletion polymorphism may result in the change of IGF2R expression levels at least in part by hsa-miR-657-mediated regulation, contributing to the elucidation for the pathogenesis of type 2 diabetes and raise the possibility that miRNAs or in combination with functional DNA sequence polymorphism may be Valuable in the treatment of human type 2 diabetes. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 26 条
[1]   Sequence variants in SLITRK1 are associated with Tourette's syndrome [J].
Abelson, JF ;
Kwan, KY ;
O'Roak, BJ ;
Baek, DY ;
Stillman, AA ;
Morgan, TM ;
Mathews, CA ;
Pauls, DA ;
Rasin, MR ;
Gunel, M ;
Davis, NR ;
Ercan-Sencicek, AG ;
Guez, DH ;
Spertus, JA ;
Leckman, JF ;
Dure, LS ;
Kurlan, R ;
Singer, HS ;
Gilbert, DL ;
Farhi, A ;
Louvi, A ;
Lifton, RP ;
Sestan, N ;
State, MW .
SCIENCE, 2005, 310 (5746) :317-320
[2]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[3]   MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias [J].
Calin, GA ;
Liu, CG ;
Sevignani, C ;
Ferracin, M ;
Felli, N ;
Dumitru, CD ;
Shimizu, M ;
Cimmino, A ;
Zupo, S ;
Dono, M ;
Dell'Aquila, ML ;
Alder, H ;
Rassenti, L ;
Kipps, TJ ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) :11755-11760
[4]   MicroRNA-133 controls cardiac hypertrophy [J].
Care, Alessandra ;
Catalucci, Daniele ;
Felicetti, Federica ;
Bonci, Desiree ;
Addario, Antonio ;
Gallo, Paolo ;
Bang, Marie-Louise ;
Segnalini, Patrizia ;
Gu, Yusu ;
Dalton, Nancy D. ;
Elia, Leonardo ;
Latronico, Michael V. G. ;
Hoydal, Morten ;
Autore, Camillo ;
Russo, Matteo A. ;
Dorn, Gerald W., II ;
Ellingsen, Oyvind ;
Ruiz-Lozano, Pilar ;
Peterson, Kirk L. ;
Croce, Carlo M. ;
Peschle, Cesare ;
Condorelli, Gianluigi .
NATURE MEDICINE, 2007, 13 (05) :613-618
[5]   A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep [J].
Clop, Alex ;
Marcq, Fabienne ;
Takeda, Haruko ;
Pirottin, Dimitri ;
Tordoir, Xavier ;
Bibe, Bernard ;
Bouix, Jacques ;
Caiment, Florian ;
Elsen, Jean-Michel ;
Eychenne, Francis ;
Larzul, Catherine ;
Laville, Elisabeth ;
Meish, Francoise ;
Milenkovic, Dragan ;
Tobin, James ;
Charlier, Carole ;
Georges, Michel .
NATURE GENETICS, 2006, 38 (07) :813-818
[6]   Regulation of soluble insulin-like growth factor II mannose 6-phosphate receptor in human serum: Measurement by enzyme-linked immunosorbent assay [J].
Costello, M ;
Baxter, RC ;
Scott, CD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :611-617
[7]   The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor [J].
Di Bacco, A ;
Gill, G .
ONCOGENE, 2003, 22 (35) :5436-5445
[8]   A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans [J].
Duggirala, R ;
Blangero, J ;
Almasy, L ;
Arya, R ;
Dyer, TD ;
Williams, KL ;
Leach, RJ ;
O'Connell, P ;
Stern, MP .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (05) :1149-1164
[9]   Identification of the insulin-like growth factor II receptor as a novel receptor for binding and invasion by Listeria monocytogenes [J].
Gasanov, U ;
Koina, C ;
Beagley, KW ;
Aitken, RJ ;
Hansbro, PM .
INFECTION AND IMMUNITY, 2006, 74 (01) :566-577
[10]   Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease [J].
Georges, Michel ;
Coppieters, Wouter ;
Charlier, Carole .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2007, 17 (03) :166-176